AtaCor Medical Raises $8.8M to Develop Substernal Cardiac Pacing System

AtaCor Medical Raises $8.8M to Develop Substernal Cardiac Pacing System

Sep 18, 2018

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. (www.atacor.com) announced today that it has completed a $8.8M Series A financing. Co-led by Boston-based Broadview Ventures and Israel-based aMoon Ventures, the financing also includes participation from a corporate partner. The investment will support the continued development of AtaCor’s revolutionary extravascular substernal cardiac pacing system.

Link to Press Release